The “Life-Saving” Heart Drug That’s Killing Women

An alarming new study has uncovered shocking news about one of the most prescribed classes of drugs in the U.S.

This popular drug has become a one-stop shop for people with heart problems. It’s prescribed for high blood pressure, arrhythmias, tremors, heart failure, and more.

But it has a dark side that I’ve been warning about for YEARS.

Now, a study has revealed that for some people, this drug is entirely useless. And for others, it could increase the risk of serious complications and death.

I’ll tell you who’s most at risk… and what you can do to stay safe.

After decades of evidence showing these popular heart drugs may harm more patients than they help, the most damning study of all was just published in the European Heart Journal.

The 2025 REBOOT trial found that taking them after a heart attack may actually increase cardiovascular problems and death, particularly in women.

Researchers studied thousands of patients who had survived a heart attack and had a left ventricular ejection fraction above 40 percent. (Ejection fraction is a measure of the heart’s ability to pump blood to the body.)

An EF of 40 percent or below indicates that your heart muscle has been weakened and is no longer functioning properly. In short, it’s a measure of heart failure.

Half of these patients were treated with beta blockers plus standard care, while the other half did not receive the drugs.

Three and a half years later, there were no differences between the groups in terms of

• Second heart attack,
• Hospitalization for heart failure, or
• Death

In other words, the beta blockers provided ZERO benefits.

But when the researchers examined the effects of beta blockers on women, things went from bad to worse.

Women taking beta blockers had a higher risk of complications and death, compared to those not taking the drugs.

The women who faced the greatest risk of complications included:

• Those whose hearts had recovered the BEST after their heart attack
• Those taking the highest doses of the drug

The worst part?

None of this is “news!”

Back in 2020, I told you about an eerily similar study showing the increased risks of beta blockers in women.

The good news is that studies like these have led to some key changes to prescribing guidelines in just the past couple of years.

For example, because of the risks of long-term use, the guidelines have changed from recommending that they be taken for three years after a heart attack to being taken for less than a year (unless there’s another reason for taking them).

Beta blockers are also no longer the go-to recommendation for treating hypertension.

The bad news is that despite the change to the official guidelines, beta blocker use has climbed from 26 million people in 2020 to 30 million in 2025.

That begs the question… why are these drugs STILL among the most frequently prescribed heart-related drugs in America? It’s another example of the Big Pharma profit machine putting profits over people.

At the end of the day, beta blockers can be life-saving if you’re having a heart attack. But they were never meant to be taken long term, and they shouldn’t be taken for high blood pressure unless other medications aren’t effective.

Your doctor should know this.

If you’re currently taking a beta blocker, I recommend reviewing the updated recommendations with your healthcare provider to ensure they’re the safest option for you.

P.S. The heart crisis NO ONE is talking about!

View Sources

Xavier Rossello, et al., Beta-blockers after myocardial infarction: effects according to sex in the REBOOT trial, European Heart Journal, 2025; ehaf673, doi:10.1093/eurheartj/ehaf673